Insider · CIK 0001949324
Lori McNeill
Files at SONN (Sonnet BioTherapeutics Holdings, Inc.). First filing -, latest -.
Lori McNeill files SEC Form 4 as director at SONN (Sonnet BioTherapeutics Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lori McNeill has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | DDisposition to issuer Common Stock | -4,394 | - | - | 0 | Dec 3, 2025 |
| Jul 11, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | AGrant or award Common Stock | +4,000 | - | - | 4,394 | Jul 15, 2025 |
| Dec 11, 2023 | SONN Sonnet BioTherapeutics Holdings, Inc. | AGrant or award Common Stock | +373 | - | - | 394 | Dec 5, 2024 |
Questions about Lori McNeill
Answered from the filings on this page, as of the latest one.
Is Lori McNeill buying or selling?
Lori McNeill has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lori McNeill's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lori McNeill has 0.
Where does Lori McNeill file Form 4?
Lori McNeill has filed Form 4 at SONN (Sonnet BioTherapeutics Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.